Following Amunts et al. (2006), we are currently segmenting subregions of the amygdala in high field MRIs of MTLs from subjects with early and advanced AD to further assess specificity of tau pathology for particular amygdalar nuclei in the context of AD. The gene discussed is MAPT; the disease is Alzheimer disease.